NSE filing, NSE: VNL. Summary written from the filing by ALFA Finder's alert engine.
Vishal Nirmiti Ltd: key numbers
- Share price
- ₹103.49
- Market cap
- ₹273.1 Cr
- Revenue (annual)
- ₹338.7 Cr
- Net profit (annual)
- ₹24.98 Cr
- Promoter holding
- 49.40%
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vishal Nirmiti Ltd
All →Vishal Nirmiti Q1 FY27 Results: Net Profit ₹6.9 Cr, Up 76.9% YoY
Vishal Nirmiti Ltd reported revenue from operations of ₹87 Cr (+35.5% YoY) and net profit of ₹6.9 Cr (+76.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹6.9 Cr · +76.9% YoY
Vishal Nirmiti Board Meeting Date
Vishal Nirmiti Ltd intimated NSE that its board will meet on 28 October 2026 to consider unaudited standalone quarterly results for the period ended June 2026. The trading window is closed from 24 October 2026 until 15 November 2026.
Vishal Nirmiti Other Announcement
Vishal Nirmiti Ltd has filed its shareholding pattern report as required by SEBI regulations.
Other results update announcements
All →Dwarikesh Sugar Industries Results Update
Dwarikesh Sugar posted a Q2 FY27 loss of ₹13.12 crore, improved from the prior-year quarter. Crushing for the 2026-27 season is set to begin in November.
Wheels India Results Update
Wheels India reported Q2 FY27 net profit of ₹53.4 Crore and revenue of ₹1,598 Crore, up 36% YoY. The company completed a ₹430 Crore fund raise.
Ambuja Cements Results Update
Ambuja Cements posted Q2 FY27 consolidated revenue of Rs 9,197 Cr with EBITDA of Rs 1,271 Cr. The firm commissioned 4.6 MTPA of new capacity amid headwinds.
- cement manufacturing capacity
- 4.6 MTPA
GK Energy Results Update
GK Energy reported Q2 FY27 revenue of ₹402.65 Crore and PAT of ₹49.36 Crore with 19,391 systems installed. H1 FY27 PAT grew 30.7% Y-o-Y to ₹109.04 Crore.
Shadowfax Technologies Results Update
Shadowfax reported Q2 FY27 revenue of ₹1,538 Cr, up 56.6% YoY, with PAT at ₹68 Cr. Sixth consecutive 55%+ growth quarter, Adj. EBITDA margin at 5.0%.
Senores Pharmaceuticals Results Update
Senores reported Q2 FY27 revenue of ₹192 cr and EBITDA of ₹58 cr, both record highs. PAT grew 22% Y-o-Y to ₹37 cr with positive FY27 outlook.